NCT00004558

Brief Summary

To determine the antiarrhythmic effects of dietary N-3 fatty acids in patients with implanted defibrillators.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Feb 1999

Longer than P75 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 1999

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 9, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 10, 2000

Completed
3.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2004

Completed
Last Updated

February 18, 2016

Status Verified

December 1, 2005

First QC Date

February 9, 2000

Last Update Submit

February 17, 2016

Conditions

Interventions

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Raitt MH, Connor WE, Morris C, Kron J, Halperin B, Chugh SS, McClelland J, Cook J, MacMurdy K, Swenson R, Connor SL, Gerhard G, Kraemer DF, Oseran D, Marchant C, Calhoun D, Shnider R, McAnulty J. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005 Jun 15;293(23):2884-91. doi: 10.1001/jama.293.23.2884.

    PMID: 15956633BACKGROUND

MeSH Terms

Conditions

Arrhythmias, CardiacHeart DiseasesTachycardia, VentricularVentricular Fibrillation

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsTachycardiaCardiac Conduction System Disease

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
PREVENTION
Sponsor Type
NIH

Study Record Dates

First Submitted

February 9, 2000

First Posted

February 10, 2000

Study Start

February 1, 1999

Study Completion

January 1, 2004

Last Updated

February 18, 2016

Record last verified: 2005-12